Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

We expect sales of the 25 and 35 mg strength to significantly improve our revenues in 2017.

It just dawned on me that no other company may even have applied for approval on the 25mg and 35mg doses... therefore PAR may be the only generic available in those strengths well beyond the 180 day exclusivity.

Look at this bit of information

Teva launched its own 5, 10, 20 and 40 mg strengths of generic Focalin XR® capsules on November 11, 2014, February 2, 2015, June 22, 2015 and November 19, 2013 respectively

They were approved on November 19, 2013 and Heck it took TEVA as much as a year and half to go to market with some doses that they had 180 day exclusivity on.

PAR may have the 25mg and 35mg market all to itself for who knows how long... GOOD FOR US!!!

Numbers... have some fun... can you find anything on that???